Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 42
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform

Alpha-synuclein misfolding as fluid biomarker for Parki...

 88

Epidermal maintenance of Langerhans cells relies on autophagy-regulated lipid metabolism

Epidermal maintenance of Langerhans cells relies on aut...

 78

Regulation of microbial gene expression: the key to understanding our gut microbiome

Regulation of microbial gene expression: the key to und...

 145